HIGHLIGHTS
- who: Ep et al. from the Division of Rheumatology, Department of Internal Medicine, Konkuk University Medical Center, Republic of have published the paper: Original article, in the Journal: (JOURNAL) of December/31,/2016
- what: The authors aimed to measure the incidence and hazard ratios (HRs) of acute coronary syndrome (ACS), stroke, CV-related mortality, MACE, VTE and arterial thromboembolism (ATE), cancer, and all-cause mortality associated with JAKi use, and compare it with TNFi use in patients with RA, using Korean nationwide health insurance data.
- how: The authors conducted a real-world retrospective . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.